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JBIR-34 and -35 produced by Streptomyces sp.
Sp080513GE-23 are nonribosomal peptides that
possess an unusual 4-methyloxazoline moiety.
Through draft genome sequencing, cosmid cloning,
and gene disruption, the JBIR-34 and -35 biosyn-
thesis gene cluster (fmo cluster) was identified; it
encodes 20 proteins including five nonribosomal
peptide synthetases (NRPSs). Disruption of one of
these NRPS genes (fmoA3) resulted in no JBIR-34
and -35 production and accumulation of 6-chloro-
4-hydroxyindole-3-carboxylic acid. Stable isotope-
feeding experiments indicated that the methyl group
of the methyloxazoline ring is derived from alanine
rather than methionine. A recombinant FmoH pro-
tein, a glycine/serine hydroxymethyltransferase ho-
molog, catalyzed conversion of a-methyl-L-serine
into D-alanine (the reverse reaction of a-methyl-L-
serine synthesis catalyzed by FmoH in vivo). Taken
together, we concluded that a-methyl-L-serine syn-
thesized from D-alanine is incorporated into JBIR-
34 and -35 to form the 4-methyloxazoline moiety.
We also propose the biosynthesis pathway of JBIR-
34 and -35.
INTRODUCTION
JBIR-34 and -35 (1 and 2) produced by Streptomyces sp.
Sp080513GE-23 are small chlorinated nonribosomal peptides
(NRPs) having aweak radical scavenging activity (Figure 1A;Mo-
tohashi et al., 2010). These compounds possess a characteristic
4-methyloxazoline moiety, which is rarely found in natural prod-
ucts. BE-32030 derivatives, which are inhibitors of cancer prolif-
eration, are the only compounds that possess this moiety other
than JBIR-34 and -35 (Figure 1B; Tsukamoto et al., 1997). Almost
all of the methyloxazoline moieties observed in natural products
are 5-methyloxazoline, which is derived from the proteinogenic
amino acid, threonine. In contrast, the 4-methyloxazoline moi-Chemistry & Biology 21, 92eties are probably derived from the nonproteinogenic amino
acid, a-methylserine, or produced by methylation of oxazoline
synthesized from serine. The similar five-membered ring,
4-methylthiazoline, which is found in the structures of yersinia-
bactin (Figure 1C), hoiamides, largazoles, and thiazohalostatin,
is synthesized via a-methylation of cysteine during peptide elon-
gation (Patel et al., 2003; Choi et al., 2010; Ungermannova et al.,
2012; Shindo et al., 1993). To date, however, there is no biosyn-
thetic study on the origin of 4-methyloxazoline.
NRPs, someofwhich have valuable bioactivities, are produced
by awide variety of microorganisms. Pharmaceutically important
antibiotics including vancomycin, daptomycin, and beta-lactam
antibiotics belong to this class, which emphasizes the
importance of NRPs in the industry (Martin, 2000; Walsh, 2004).
They also attract interest because combinatorial biosynthesis
can be applied for production of novel NRPs (Walsh, 2004).
Typical nonribosomal peptide synthetases (NRPSs) show
modular structure, and each module is responsible for the
condensation of one amino acid. One module is usually
composed of three domains, condensation (C) domain, adenyla-
tion (A) domain, and thiolation (T) domain. The T domain is a
carrier protein containing a serine residue that is phosphopante-
theinylated; an amino acid or a growing peptide is covalently
attached to the phosphopantetheine arm via a thioester bond.
The A domain is responsible for amino acid selection and
catalyzes formation of a thioester bond between the phospho-
pantetheine arm of the T domain and an amino acid substrate
by consuming ATP. The C domain is responsible for the peptide
bond formation between an amino acid attached to one Tdomain
and the growing peptide (or an amino acid in the initial condensa-
tion) attached to another T domain. Sometimes, a module con-
tains an accessory enzyme domain such as methyltransferase
(MT) domain and epimerization (E) domain to modify the growing
peptide or amino acid before condensation. In some cases, the
C domain is substituted by the heterocyclization (CYC) domain,
catalyzing formation of the oxazoline or thiazoline ring. In the
end, the synthesized peptide is cleaved off from the enzyme by
the thioesterase (TE) domain, which catalyzes simple hydrolysis
or macrocycle formation. This modular structure enabled engi-
neering of NRPSs to produce various peptides by substituting
A domains, which are responsible for amino acid selection.
Nguyen et al. (2006) successfully produced daptomycin analogs3–934, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 923
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Figure 1. Structures of the Compounds
(A and B) JBIR-34, -35 (A), and BE-32030 derivatives (B) possess a distinct 4-methyloxazoline moiety.
(C) Yersiniabactin and micacocidin possess a 4-methylthiazoline moiety, which is derived from cysteine via methylation by a SAM-dependent methyltransferase.
(D) Amicetin possesses an a-methyl-L-serine moiety attached to the aromatic amine group.
(E and F) 6-Chloro-4-hydroxyindole-3-carboxylic acid (E) and N-(6-chloro-4-hydroxyindole-3-carboxyl)-a-methyl-L-serine (F) were isolated from Streptomyces
sp. Sp080513GE-23 in this study and are intermediates of JBIR-34 and -35 biosynthesis.
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Biosynthetic Origin of Unusual 4-Methyloxazolineby engineering the daptomycin-biosynthesis NRPSs. A fasci-
nating feature of NRPSs is their ability to use nonproteinogenic
amino acids (Walsh et al., 2013). For instance, hydroxyphenylgly-
cine, ornithine, and alkylproline moieties are observed in vanco-
mycin, daptomycin, and sibiromycin, respectively (Recktenwald
et al., 2002;Miao et al., 2005; Li et al., 2009). Incorporation of non-
proteinogenic amino acids is important for their structural diver-
sity and bioactivity. Therefore, exploring the enzymatic chemistry
of the A domain for incorporation of novel nonproteinogenic
amino acids could enhance the structural diversity of NRPs
because it would be available for combinatorial biosynthesis.
Glycine/serine hydroxymethyltransferase is a pyridoxal-50-
phosphate (PLP)-dependent enzyme and catalyzes the forma-
tion of serine from glycine using 5,10-methylenetetrahydrofolate
(mTHF) as a hydroxymethyl group donor. It is also predicted to
be responsible for biosynthesis of nonproteinogenic amino acids
in secondary metabolite biosynthesis; AmiS in amicetin biosyn-
thesis by Streptomyces vinaceusdrappus NRRL 2363 has been
hypothesized to catalyze a-methylserine synthesis using alanine
instead of glycine as a substrate (Zhang et al., 2012). In addition
to AmiS, there are two examples of enzymes that catalyze the
conversion between D-alanine and a-methyl-L-serine. These en-
zymeswere purified fromParacoccus sp. AJ110402 (BAG31000)
and Aminobacter sp. (BAG31001) and characterized in vitro (No-
zaki et al., 2008, 2009). A neighbor of glycine/serine hydroxyme-
thyltransferase, threonine aldolase, has recently been attracting
attention as an enzyme for synthesizing nonproteinogenic amino
acids. Barnard-Britson et al. (2012) have shown that LipK is
a transaldolase that synthesizes the b-hydroxy-a-amino acid,
50-C-glycyluridine, in A-90289 biosynthesis. Glycine/serine hy-
droxymethyltransferase and threonine aldolase are promising
biocatalysts for forming various b-hydroxy-a-amino acids
(Schirch and Gross, 1968; Gutierrez et al., 2008), because these
reactions are stereospecific.924 Chemistry & Biology 21, 923–934, August 14, 2014 ª2014 ElseviIn this study, we analyzed the biosynthesis of JBIR-34 and -35
by identifying their biosynthesis gene cluster, disrupting an
NRPS gene, stable isotope-feeding experiments, and in vitro
enzyme assays. We mainly focused on the biosynthesis origin
of an intriguing 4-methyloxazoline ring and revealed that it is
synthesized from a-methyl-L-serine. This key intermediate is
synthesized from D-alanine by FmoH, which is a glycine/serine
hydroxymethyltransferase homolog. Taken together with several
other results, we predicted the entire biosynthesis pathway of
JBIR-34 and -35.
RESULTS
Search for JBIR-34 and -35 Biosynthesis Intermediates
To obtain insight into the biosynthesis pathway of JBIR-34 and
-35, we attempted to isolate JBIR-34 and -35 derivatives from
the culture broth of the producer strain. We assumed that the
chlorine group of these compounds is incorporated at an early
stage of biosynthesis and searched for compounds containing
a chlorine group using liquid chromatography-mass spectrom-
etry (LC-MS) analysis. Compounds containing a chlorine group
showacharacteristic isotopepattern,which enables us to search
for chlorine-containing compounds only with LC-MS. As a result,
we succeeded in the detection of two compounds (compounds 3
and 4), which showed [M + H]+ monoisotopic ions at m/z 212
and 313, respectively. These compounds were purified and their
structures were analyzed with 1H nuclear magnetic resonance
(NMR), 13C NMR, correlated spectroscopy (COSY), heteronu-
clear multiple-quantum correlation (HMQC), and heteronuclear
multiple bond correlation (HMBC). Compounds 3 and 4 were
identified as 6-chloro-4-hydroxyindole-3-carboxylic acid (Fig-
ure 1E; Figure S1A available online) and N-(6-chloro-4-hydrox-
yindole-3-carboxyl)-a-methyl-L-serine (Figures 1F and S1B),
respectively. The stereochemistry of a-methyl-L-serine waser Ltd All rights reserved
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Bru¨ckner, 2004). Isolation of these chlorinated compounds sup-
ported our hypothesis that chlorination of the indole moiety oc-
curs at an early stage of the biosynthesis. These compounds
seem to be intermediates released fromNRPSduring the peptide
synthesis. The isolation of compound 4, which seems to be an
intermediate before heterocyclization to form the 4-methyloxa-
zoline moiety, suggests that the 4-methyloxazoline moiety is
synthesized via a-methyl-L-serine, although it was not clear
whether a-methyl-L-serine was used as a substrate of NRPS or
synthesized bymethylation of L-serine during peptide elongation.
Cloning and Sequencing of JBIR-34 and -35
Biosynthesis Gene Cluster
First, we performed a draft genome sequencing of Strepto-
myces sp. Sp080513GE-23. However, the quality was not
good enough to reveal the entire sequence of the putative
JBIR-34 and -35 biosynthesis gene cluster, which was later
named fmo (four methyl oxazoline) cluster. Second, to clone
and determine the accurate nucleotide sequence of the fmo
gene cluster, we constructed a cosmid library of the genomic
DNA of Streptomyces sp. Sp080513GE-23 using pTOYAMA-
cos (Onaka et al., 2003). Using a flavin-dependent halogenase
gene (fmoD), which was discovered by the draft genome
sequence, as a probe for colony hybridization, we obtained a
cosmid (pTOYAMAcos cl. 15) carrying part of the fmo gene
cluster. Next, we obtained another cosmid (pTOYAMAcos
C56) carrying the remaining part of the fmo gene cluster by
colony hybridization using an NRPS gene (fmoA5) as a probe,
which is included in the insert fragment of pTOYAMAcos cl.15.
Then, we determined the nucleotide sequence of the inserts of
these two cosmids, to reveal the entire sequence of the fmo
gene cluster (Table 1 and Figure 2). To prove by heterologous
expression that the fmo gene cluster is responsible for the
biosynthesis of JBIR-34 and -35, we constructed a cosmid
(pTJ34-3) carrying the entire fmo gene cluster (see Supple-
mental Experimental Information). However, we could not
observe heterologous production of JBIR-34 or -35 by Strep-
tomyces lividans or Streptomyces albus harboring pTJ34-3.
Therefore, we disrupted fmoA3 encoding an NRPS in Strepto-
myces sp. Sp080513GE-23 (Figure S2). The DfmoA3 mutant
did not produce both JBIR-34 and -35 (Figure 3), which clearly
showed that this gene cluster is responsible for their biosyn-
thesis. Furthermore, the DfmoA3 mutant produced a larger
amount of compound 3 (approximately 0.3 mg/l) than the
wild-type strain (approximately 0.1 mg/l), which suggested
that this compound was the priming unit for the NRP synthe-
sis. The wild-type strain produced approximately 7 and
2 mg/l of JBIR-34 and -35, respectively, and the amount of
compound 3 produced by the DfmoA3 mutant was therefore
much lower than expected. This result may be attributed to
the product inhibition of the enzyme involved in the biosyn-
thesis of compound 3. The DfmoA3 mutant showed normal
growth and morphological development on ISP2 agar (data
not shown).
In Silico Analysis of NRPSs and Related Enzymes
Topredict the biosynthesis pathway of JBIR-34 and -35, proteins
encoded by the fmo cluster were analyzed in silico. FmoA1 isChemistry & Biology 21, 92composed of an A-T didomain. Using NRPSpredictor2 (http://
nrps.informatik.uni-tuebingen.de/Controller?cmd=SubmitJob;
Ro¨ttig et al., 2011), theAdomainwaspredicted to recognize tryp-
tophan. Importantly, FmoA1 showed significant similarity to
several didomain NRPSs, such as SimH (36% identity) from the
simocyclinone biosynthesis gene cluster (Galm et al., 2002),
NovH (35%) from the novobiocin biosynthesis gene cluster (Stef-
fensky et al., 2000;Chen andWalsh, 2001), andNikP1 (32%) from
the nikkomycin biosynthesis gene cluster (Chen et al., 2002).
These NRPSs were predicted or proved to be responsible for
b-hydroxylation of tyrosine or histidine in collaboration with a
cytochrome P450, which is encoded by a gene adjacent to the
NRPS genes. Furthermore, the fmoA1 gene is located adjacent
to fmoC that encodes a putative cytochrome P450 showing
similarity to NikQ (39%), SimI (37%), and NovI (33%), which
were predicted or proved to catalyze b-hydroxylation of amino
acids attached to T domain. Thus, FmoA1 and FmoC are likely
to be responsible for b-hydroxylation of tryptophan or its deriva-
tive. The resulting b-hydroxyamino acid can be cleaved to
give an aldehyde and glycine by a threonine aldolase-catalyzed
retro-aldol reaction (di Salvo et al., 2014). The resulting aldehyde
can be further oxidized to a carboxylic acid by an aldehyde dehy-
drogenase (Kostichka et al., 2001). FmoM and FmoI, which are
threonine aldolase and aldehyde dehydrogenase homologs,
respectively, appeared to be responsible for these reactions,
and it was therefore highly likely that FmoA1 was involved in the
biosynthesis of compound 3 (6-chloro-4-hydroxyindole-3-car-
boxylic acid), which is the putative priming unit for the NRP
synthesis.
FmoA2 is composed of A, T, and CYC domains followed by an
MT domain. FmoA3 possesses CYC, A, and T domains. Because
these enzymes possess a CYC domain, they are likely to be
responsible for the formation of the methyloxazoline group.
However, the A domains of FmoA2 and FmoA3 were predicted
by the NRPSpredictor2 to recognize alanine and cysteine,
respectively. According to the domain structure of FmoA2 and
FmoA3, we postulated two possible biosynthesis pathways for
4-methyloxazoline. In the first hypothesis,N-(6-chloro-4-hydrox-
yindole-3-carboxyl)-L-serinyl-T domain is synthesized from
6-chloro-4-hydroxyindole-3-carboxylic acid (3) and L-serine by
FmoA2 and FmoA3. This compound is then methylated by the
MT domain of FmoA2 to synthesize N-(6-chloro-4-hydroxyin-
dole-3-carboxyl)-a-methyl-L-serinyl-T domain, which is further
heterocyclized by the CYC domains of FmoA2 and/or FmoA3
to form the 4-methyloxazoline moiety. This pathway is similar
to that for 4-methylthiazoline formation in the biosynthesis of
yersiniabactin (Patel et al., 2003). In the second hypothesis,
N-(6-chloro-4-hydroxyindole-3-carboxyl)-a-methyl-L-serinyl-T
domain is synthesized directly from 6-chloro-4-hydroxyindole-3-
carboxylic acid (3) and a-methyl-L-serine by FmoA2 and FmoA3.
a-Methyl-L-serine may be synthesized from alanine by FmoH, a
homolog of AmiS (58.2%), BAG31000 (41.3%), and BAG31001
(41.3%; Zhang et al., 2012; Nozaki et al., 2008, 2009).
FmoA4 is composed of C, A, T, and MT domains. This A
domain was predicted by the NRPSpredictor2 to incorporate
isoleucine, but this prediction is not consistent with the struc-
tures of JBIR-34 and -35. Because FmoA4 contains neither
CYC domain nor TE domain, it is not likely to be involved in
oxazoline ring formation or the last peptide bond formation.3–934, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 925
Table 1. Biosynthesis Gene Cluster of JBIR-34 and -35
Open Reading
Frame
No. of
Amino Acids Proposed Function Protein Homolgy
Amino Acid
Identity (%)
orf1 368 metalloprotease metalloprotease [Streptomyces
mobaraensis NBRC 13819] ZP_23070617.1
142/371 (38)
fmoR1 289 SARP-family
transcriptional regulator
SARP-family transcriptional regulator
[Amycolatopsis mediterranei U32]
YP_003765343
102/241 (42)
fmoA1 588 NRPS (A-T) SimH [Streptomyces antibioticus]
AF321122_3
208/583 (36)
fmoB 246 thioesterase AnaA [Anabaena sp. 37] AEQ38173.1 78/240 (33)
fmoC 398 cytochrome P450
monooxygenase
NikQ [Streptomyces tendae]
CAC11139.1
156/400 (39)
fmoD 550 tryptophan 6-halogenase KtzQ [Kutzneria sp. 744] ABV56597.1 307/526 (58)
fmoE 177 flavin reductase KtzS [Kutzneria sp. 744] ABV56599.1 74/157 (47)
fmoA2 1,496 NRPS (A-T-CYC-MT) NRPS [Kribbella flavida DSM 17836]
YP_003381984.1
477/1085 (44)
fmoF 218 hypothetical protein hypothetical protein WSS_A10807
[Rhodococcus opacus M213]
ZP_14478590.1
95/206 (46)
fmoG 423 integral membrane
ion antiporter
ForY [Micromonospora olivasterospora]
CAF31532.1
199/406 (49)
fmoH 407 alanine/a-methylserine
hydroxymethyltransferase
glycine/serine hydroxymethyltransferase
[Streptomyces hygroscopicus subsp.
jinggangensis 5008] YP_006242991.1
235/402 (58)
fmoA3 1,127 NRPS (CYC-A-T) CurF [Lyngbya majuscula] AAT70101.1 428/1101 (39)
fmoI 490 aldehyde dehydrogenase betaine-aldehyde dehydrogenase
[Thermobifida fusca YX] YP_289834.1
251/465 (54)
fmoJ 246 esterase esterase [Saccharopolyspora erythraea
NRRL 2338] YP_001105518.1
126/248 (51)
fmoR2 323 transcriptional regulator helix-turn-helix, type 11 [Micromonospora
sp. L5] YP_004081693.1
163/316 (52)
fmoA4 1,459 NRPS (C-A-T-MT) NRPS [Myxococcus stipitatus
DSM 14675] YP_007359089.1
448/1077 (42)
fmoK 487 transmembrane transporter transmembrane efflux protein
[Streptosporangium roseum
DSM 43021] YP_003342489.1
219/473 (46)
fmoA5 1,868 NRPS (C-T-TE-TE-A-T) NRPS [Streptomyces fungicidicus]
ABD65960.1
363/804 (45)
fmoL 390 hypothetical protein hypothetical protein [Streptomyces
tsukubaensis] WP_006346030.1
157/338 (46)
fmoM 364 L-threonine aldolase threonine aldolase [Streptosporangium
roseum DSM 43021] YP_003344742.1
164/350 (47)
fmoR3 306 LysR-family transcriptional
regulator
LysR-family transcriptional regulator
[Streptomyces sp. SirexAA-E]
YP_004802185.1
171/293 (58)
orf2 148 hypothetical protein hypothetical protein [Streptomyces
bottropensis] WP_005481797.1
62/119 (52)
orf3 140 endoribonuclease L-PSP
family protein
endoribonuclease L-PSP [Streptomyces
ipomoeae] WP_009312170.1
114/129 (88)
orf4 386 acyl-CoA dehydrogenase acyl-CoA dehydrogenase [Streptomyces
zinciresistens] WP_007496998.1
326/385 (85)
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Biosynthetic Origin of Unusual 4-MethyloxazolineTherefore, we assumed that FmoA4 catalyzes condensation of
alanine (a probable amino acid for the second elongation
step). The MT domain of FmoA4 may be involved in methylation
of the indole ring.926 Chemistry & Biology 21, 923–934, August 14, 2014 ª2014 ElseviFmoA5 has the domain structure of C-T-TE-TE-A-T. This A
domain was predicted by the NRPSpredictor2 to incorporate
serine or threonine. Because FmoA5 possesses TE domains,
this enzyme seems to catalyze the formation of the last peptideer Ltd All rights reserved
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Figure 2. Biosynthesis Gene Cluster of JBIR-34 and -35
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Biosynthetic Origin of Unusual 4-Methyloxazolinebond in the JBIR-34 and -35 biosynthesis. This is consistent with
the NRPSpredictor2 prediction; according to the structures of
JBIR-34 and -35, serine should be the last amino acid to be
incorporated. The two TE domains were subjected to phyloge-
netic analysis with various type I and type II TE domains, accord-
ing to the procedure reported by Buntin et al. (2010), in an
attempt to predict their functions (Figure S3). Type I TE is gener-
ally responsible for the release of a fully elongated peptide from
the enzyme, whereas type II TE is involved in the ‘‘proofreading’’
of the peptide during the elongation process, i.e., the cleavage of
any mistakenly loaded acyl moieties from the T domain (Koglin
et al., 2008). The phylogenetic tree showed that the TE domain
closer to the N terminus belonged to a clade composed of
type I TE domains from the NRPSs involved in the biosynthesis
of albicidin and thailandamide (Royer et al., 2004; Ishida et al.,
2010), whereas the TE domain closer to the C terminus belonged
to a clade which mainly contained type II TEs. This result sug-
gested that these two TEs performed different functions in the
biosynthesis of JBIR-34 and -35. The observation that FmoA5
possessed a putative type II TE domain in cis was particularly
interesting, because most type II TEs exist in trans (Koglin
et al., 2008). FmoA5 also possessed two T domains, which
both had a conserved Ser residue that was capable of binding
to phosphopantetheine. It was difficult to predict which T domain
was involved in the peptide elongation process.
As described above, the prediction of the substrate specificity
of more than half of the A domains did not match with the struc-
tures of JBIR-34 and -35. These A domains may select unusual
amino acids, which would make it difficult for the NRPSpredic-
tor2 to predict the genuine amino acid substrate.
The C domains of FmoA4 and FmoA5were analyzed by phylo-
genetic analysis according to the procedure reported by Rausch
et al. (2007). We found that both of them belong to the LCL
domain, which catalyzes peptide bond formation between two
L-amino acids (data not shown).
Feeding of [Methyl-13C]-Methionine and [3-13C]-Alanine
To deduce the biosynthetic origin of the methyl group of the
methyloxazoline moiety, we carried out feeding experiments us-
ing a stable isotope. Prior to the feeding experiments, we
analyzed JBIR-34 with high-resolution tandem mass spectrom-
etry (HR-MS/MS) and observed three major fragments, A (m/
z = 348.1106 [M + H]+), B (m/z = 277.0735 [M + H]+), and C (m/
z = 222.0315 [M + H]+; Figure S4A). Importantly, each fragment
showed an ion that was 2 Da larger than the corresponding
monoisotopic ion (the difference came from 37Cl), demonstrating
that each fragment contained chloride. Based on this result, we
determined the molecular formulas of the fragments: A,
C17H19ClN3O3
+; B, C14H14ClN2O2
+; and C, C11H9ClNO2
+.
Furthermore, taking the structure of JBIR-34 into consideration,Chemistry & Biology 21, 92we concluded that fragment A is generated by a type cleavage
of the amide bond between serine and alanine (Figure S4B).
Similarly, fragment B is generated by a type cleavage of the
amide bond between alanine and methyloxazoline (Figure S4B).
Fragment C is derived from the hydrolysis of themethyloxazoline
moiety followed by b type cleavage of the peptide bond (Fig-
ure S4B). We also observed a similar fragmentation pattern of
JBIR-35 (Figures S4C and S4D). Thus, we concluded that
incorporation of 13C into the methyloxazoline moiety could be
detected by comparing the isotopic composition of fragments
B and C.
We initially expected that the methyl group of the methyloxa-
zoline moiety would be synthesized by a SAM-dependent meth-
yltransferase (for example, the MT domain of FmoA2), because
the methylthiazoline moiety in yersiniabactin has been predicted
to be synthesized via methylation of cysteine catalyzed by the
MT domain of NRPS (Patel et al., 2003). To test this, [meth-
yl-13C]-methionine was added to the medium and incubated
with Streptomyces sp. Sp080513GE-23. The resulting JBIR-34
was analyzed by HR-MS/MS to examine the incorporation of
13C. The m/z value of the parent ion [M + H]+ of JBIR-34
increased from 481.1473 to 483.1546, suggesting that two 13C
atoms were incorporated into the peptide (Figure S4E). The
MS data suggested that almost all of the JBIR-34 had been
labeled with two 13C atoms. Furthermore, the m/z values of the
A, B, and C fragments increased by 2, which was consistent
with the incorporation of two 13C atoms. In contrast to our expec-
tation, this result indicated that the two methyl groups of the
indole chromophore came from methionine, and that the methyl
group of the 4-methyloxazoline ring was not derived from methi-
onine (Figure S4E).
Next, we hypothesized that the methyloxazoline moiety may
be formed by heterocyclization of a-methyl-L-serine, which
could be synthesized from D-alanine by FmoH, a homolog of
AmiS in the amicetin biosynthesis (Zhang et al., 2012). To test
our second hypothesis, we fed [3-13C]-L-alanine, which seems
to be easily converted to [3-13C]-D-alanine in vivo, to Strepto-
myces sp. Sp080513GE-23. The produced JBIR-34 was
analyzed by HR-MS/MS to examine the incorporation of 13C.
The parent ion of JBIR-34 showed several peaks in addition to
the native peaks; there were two strong peaks corresponding
to two ions that were 1 and 2 Da larger than the monoisotopic
parent ion (Figure S4F). This result suggested that two alanine
molecules could be incorporated into JBIR-34. Analysis by
mass spectroscopy revealed that approximately 46% and 39%
of the JBIR-34 had been labeled with one and two 13C atoms,
respectively. Fragment A also showed a similar isotopic compo-
sition to the parent ion (Figure S4F). In contrast, fragment B
showed a different isotopic composition from the parent ion
and fragment A; approximately 58% and 6% of JBIR-34 were3–934, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 927
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Figure 3. LC-MS Analysis of the Compounds
LC-MS analysis of the compounds produced by Streptomyces sp.
Sp080513GE-23 wild-type (A) and DfmoA3 mutant (B). The DfmoA3 mutant
did not produce JBIR-34 (1) or -35 (2). However, it produced larger amounts of
compound 3 than the wild-type strain. The production of 3 and 4 by the wild-
type strain could not be detected in these conditions, because the yields of
these compounds were very low.
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Biosynthetic Origin of Unusual 4-Methyloxazolinelabeled with one 13C and two 13C, respectively. The most abun-
dant ion of fragment B was 1 Da larger than themonoisotopic ion
and the ratio of the 2 Da-larger ion to the 1 Da-larger ion was
much lower than that in the parent ion or fragment A (Figure S4F),
suggesting that only one alanine molecule was incorporated into
fragment B. Furthermore, the ratio of isotopes observed in frag-
ment C was similar to the ratio observed in JBIR-34 obtained
from medium without [3-13C]-L-alanine, indicating that no
alanine was incorporated into fragment C. Taken together, we
concluded that [3-13C]-L-alanine was incorporated into the
methyloxazoline moiety. In addition, [3-13C]-L-alanine was simi-
larly incorporated into compound 4 (data not shown). These re-
sults clearly support our second hypothesis.
In Vitro Analysis of FmoH
To investigate the activity of FmoH, we prepared a recombinant
FmoH protein using the pET system in Escherichia coli. A
histidine tag was fused to the N terminus of the recombinant
protein, and it was purified by Ni2+ affinity chromatography (Fig-
ure 4A). The purified FmoH did not show any UV absorbance
above 300 nm (data not shown), which indicated that FmoH, in
contrast to typical PLP-dependent enzymes, was not copurified
with PLP (Schirch and Gross, 1968; Nozaki et al., 2008). We
assumed that FmoH would catalyze the formation of a-methyl-
serine from alanine coupled with the conversion of mTHF to tet-
rahydrofolate (THF). However, we analyzed the reverse reaction,
becausemTHFwas not commercially available. FmoHwas incu-928 Chemistry & Biology 21, 923–934, August 14, 2014 ª2014 Elsevibated with a-methyl-L-serine or a-methyl-D-serine and THF.
The products were derivatized using Na-(5-fluoro-2,4-dinitro-
phenyl)-L-leucineamide (L-FDLA) and analyzed with LC-MS
according to the method described previously (Motohashi
et al., 2010; Bhushan and Bru¨ckner, 2004). We observed the
conversion of a-methyl-L-serine to D-alanine (Figure S5D);
however, a-methyl-D-serine was not converted to alanine
(Figure S5C). This result suggests that FmoH is capable of syn-
thesizing a-methyl-L-serine from D-alanine by transferring a
hydroxymethyl group from mTHF. Based on this result, we
analyzed the FmoH-catalyzed reaction in vitro using 9-fluorenyl-
methyloxycarbonyl chloride instead of L-FDLA to derivatize the
reaction products. Derivatization with 9-fluorenylmethyloxycar-
bonyl chloride allowed for the quantification to be conducted
with a higher level of sensitivity. Removal of THF from the
FmoH reaction mixture revealed that the production of D-alanine
had not occurred, which indicated that THF was essential for the
reaction (Figure 4B). Furthermore, the removal of PLP from the
reactionmixture led to a 20% reduction in the rate of the reaction
(Figure 4B). This result suggested that some of the recombinant
FmoH proteins were retaining PLP, even after the purification
process. The substrate specificity of FmoH was then analyzed
using a-methyl-L-serine, a-methyl-D-serine, L-serine, and D-
serine as substrates (Figures 4C and 4D). Among these sub-
strates, FmoH exhibited a preference for a-methyl-L-serine,
which was converted to alanine with a high level of efficiency.
Alanine was also synthesized from a-methyl-D-serine by FmoH,
but the rate of the reaction was very low. Furthermore, FmoH
catalyzed the conversion of L-serine to glycine, but the rate of
the reaction was also very low (Figures 4C and 4D). The kcat
and Km values for the synthesis of D-alanine from a-methyl-L-
serine were determined to be 0.40 ± 0.02 min1 and 105 ±
9 mM, respectively (Figure 4E). The Km value was lower than
that reported for the synthesis of glycine (900 mM) from L-serine
using the glycine/serine hydroxymethyltransferase from Bacillus
stearothermophilus (Pai et al., 2009), which suggested that
a-methyl-L-serine is the physiological product of the in vivo
FmoH reaction. Taken together, these characteristic properties
of recombinant FmoH strongly supported our hypothesis that
FmoH is the a-methyl-L-serine synthase involved in the biosyn-
thesis of JBIR-34 and -35.
Substrate Specificities of A Domains in the fmo Cluster
To obtain further insight into the biosynthesis of JBIR-34 and
-35, we attempted to analyze the substrate specificity of the
A domains of FmoA proteins. The adenylating activity of each
FmoA protein was analyzed by a previously described proce-
dure with some modifications (McQuade et al., 2009; Kadi
and Challis, 2009). In this assay, pyrophosphate formed with
acyl-AMP was hydrolyzed to phosphate by pyrophospha-
tase. The resultant phosphate was quantified using a malachite
green phosphate assay kit (BioAssay Systems). The full-length
recombinant proteins of each FmoA were prepared for this
analysis. Although the recombinant FmoA1 efficiently catalyzed
the adenylation of tryptophan and 6-chlorotryptophan, it
showed a clear preference for 6-chlorotryptophan over trypto-
phan (Figure 5A). This result indicates that halogenation of
the indole ring occurs at an early stage of the biosynthesis.
The recombinant FmoA2 seemed to specifically accepter Ltd All rights reserved
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Figure 4. In Vitro Analysis of FmoH
(A) SDS-PAGE analysis of purified FmoH.
(B) Cofactor dependence of the reaction catalyzed by FmoH. FmoH required THF for the synthesis of D-alanine. The addition of PLP enhanced the reaction, which
supported the observation that FmoH was not copurified with PLP. The box indicates the derivatized alanine.
(C) LC-ESI MS analysis of the products synthesized by FmoH after derivatization. Significant quantities of alanine were synthesized when FmoH was incubated
with a-methyl-L-serine. In contrast, the incubation of FmoH with a-methyl-D-serine and L-serine resulted in the synthesis of trace amounts of alanine and glycine,
respectively. The boxes drawn with solid and broken lines indicate the derivatized alanine and glycine compounds, respectively.
(D) The activity of FmoH in the synthesis of alanine or glycine from different substrates. Error bars represent SEM (n = 3).
(E) Kinetic analysis of FmoH using a-methyl-L-serine as a substrate. Error bars represent SEM (n = 3).
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Biosynthetic Origin of Unusual 4-Methyloxazoline6-chloro-4-hydroxyindole-3-carboxylic acid (3; Figure 5B). This
result is consistent with the previous observation that com-
pound 3 accumulated in the DfmoA3 mutant. The recombinant
FmoA3 showed significant adenylating activity when it was
incubated with a-methyl-L-serine, suggesting that a-methyl-L-
serine is the physiological substrate of the A domain of
FmoA3 (Figure 5C). This result supports our hypothesis that
4-methyloxazoline is synthesized from a-methyl-L-serine. Re-
combinant FmoA4 preferred D-alanine as a substrate, and this
result was consistent with the structures of JBIR-34 and -35.
Although the substrate specificity of FmoA5 appeared to beChemistry & Biology 21, 92relatively broad, it showed a significant preference for L-serine.
This result was also consistent with the structures of JBIR-34
and -35.
DISCUSSION
According to our results, we propose that JBIR-34 and -35 are
synthesized as follows (Figure 6). First, tryptophan is haloge-
nated by the activity of FmoD. FmoE, a flavin reductase,
probably stimulates the halogenation by reducing the flavin
cofactor, which is essential for halogenation. The obtained3–934, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 929
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Figure 5. Amino Acid Selectivity of the FmoA Proteins
(A–E) The relative adenylation activity was estimated by quantifying phosphate using the malachite green phosphate assay kit. Phosphate was produced from
pyrophosphate, which was produced during the adenylation of amino acids (or compound 3). Error bars represent SEM (n = 3).
(A) The FmoA1 preferred 6-chloro-L-tryptophan to other amino acids.
(B) The FmoA2 preferred 6-chloro-4-hydroxyindole-3-carboxylic acid (3).
(C) FmoA3 preferred a-methyl-L-serine.
(D) FmoA4 preferred D-alanine.
(E) FmoA5 preferred L-serine.
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Biosynthetic Origin of Unusual 4-Methyloxazoline6-chlorotryptophan is then activated by FmoA1 and covalently
bindswith the active site of the T domain of FmoA1 via a thioester
bond. The 6-chlorotryptophan attached to FmoA1 is oxidized to
b-hydroxyamino acid by the activity of FmoC, a heme-iron-
dependent monooxygenase. Based on our present results, we
could not completely clarify at which stage the hydroxylation of
the indole ring occurs. We assumed that FmoC is a dual function
P450, which catalyzes hydroxylation of the indole ring in addition
to b-hydroxylation. As there are several examples of P450 that
catalyzes hydroxylation at different positions (Podust and Sher-
man, 2012), this hypothesis is not astounding. A dihydroxy inter-
mediate is then released from the T domain by the activity of930 Chemistry & Biology 21, 923–934, August 14, 2014 ª2014 ElseviFmoB. The released intermediate is then converted to 6-
chloro-4-hydroxyindole-3-carboxylic acid (3) by retro-aldol reac-
tion catalyzed by FmoM and oxidation catalyzed by FmoI. In
parallel, a-methyl-L-serine is synthesized from D-alanine by the
activity of FmoH. FmoA2, FmoA3, FmoA4, and FmoA5 assemble
6-chloro-4-hydroxyindole-3-carboxylic acid with a-methyl-L-
serine, D-alanine, and L-serine to form a linear peptide. 4-Methyl-
oxazoline formation occurs during the peptide elongation, when
the intermediate is attached to FmoA3. The methylations of
the indole ring are probably catalyzed by the MT domains of
FmoA2 and FmoA4 during the peptide elongation. The D-alanine
used for the synthesis of the a-methyl-L-serine and theer Ltd All rights reserved
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Figure 6. Proposed Biosynthesis Pathway of JBIR-34 and -35
First, 6-chloro-4-hydroxyindole-3-carboxylic acid (3) is synthesized from tryptophan (A) and a-methyl-L-serine is synthesized from D-alanine (B). Compound 3 is
assembled with a-methyl-L-serine, D-alanine, and L-serine by four NRPSs, FmoA2, FmoA3, FmoA4, and FmoA5, resulting in JBIR-34 and -35 (C). Themethylation
of the indole moiety is probably catalyzed by the MT domains of FmoA2 and FmoA4.
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Biosynthetic Origin of Unusual 4-Methyloxazolineelongation of the peptide was presumably synthesized by the
alanine racemase involved in the biosynthesis of peptidoglycan
(Radkov and Moe, 2014). Only one alanine racemase gene was
found in the draft genome sequence of Streptomyces sp.
Sp080513GE-23, and the product of this gene showed a high
level of sequence homology to the alanine racemase from Strep-
tomyces coelicolor A3(2) (82% identity). It is highly likely that the
enzyme encoded by this gene would be responsible for the
biosynthesis of D-alanine in Streptomyces sp. Sp080513GE-23.
The most important enzyme for 4-methyloxazoline moiety
biosynthesis is FmoH, which catalyzes the formation of
a-methyl-L-serine from D-alanine and mTHF. To date, there are
only a few natural products that are composed of a-methylser-
ine. Amicetin isolated from S. vinaceusdrappus NRRL 2363, cit-
reamicins fromMicromonospora citrea (Carter et al., 1990), con-
agenin from Streptomyces roseosporus (Yamashita et al., 1991),
neocitreamicins fromNocardia (Peoples et al., 2008), oxamicetin
(Konishi et al., 1973) from Arthrobacter oxamicetus sp. nov.,
piperazimycin from marine-derived Streptomyces (Miller et al.,
2007), JBIR-111 from Streptomyces sp. RM72 (Hosoya et al.,
2012), and JBIR-39 from Streptomyces sp. Sp080513SC-24
(Kozone et al., 2011) are almost all natural products reported
to contain an a-methylserine moiety. FmoH homologs are prob-
ably involved in the biosynthesis of these compounds. Indeed,Chemistry & Biology 21, 92the biosynthesis gene cluster of amicetin has an FmoH homolog
and this enzyme has been predicted to be responsible for
a-methyl-L-serine synthesis (Zhang et al., 2012). However, the
activity of this enzyme was not biochemically elucidated. Our
in vitro analysis of FmoH is a characterization of a-methyl-L-
serine synthase that correlates with NRP biosynthesis.
To date, there are only a few examples of A domains that
are predicted to recognize a-methyl-L-serine. Therefore, there
is still not enough information to deduce the selectivity of
these A domains. Further examples of A domains recognizing
a-methyl-L-serine and structural elucidation of the domains are
required to reveal the amino acid residues that are responsible
for the recognition of a-methyl-L-serine. By BLAST search using
FmoH as a query, we discovered several FmoH homologs
that are encoded adjacent to the NRPS genes in Azospirillum
sp. B510, Streptomyces hygroscopicus subsp. jinggangensis
5008, Streptomyces griseus subsp. griseus NBRC 13350, Bacil-
lus amyloliquefaciens DSM 7, and Pseudomonas sp. GM17. We
built a phylogenetic tree using the A domains of FmoH-related
NRPSs and typical NRPSs, such as the NRPS responsible for
daptomycin biosynthesis, and found that these FmoH-related
NRPSs, except for NRPSs from S. hygroscopicus subsp. jing-
gangensis 5008, have one A domain that falls into the same
clade as the A domains from FmoA3 and AmiT, which is the3–934, August 14, 2014 ª2014 Elsevier Ltd All rights reserved 931
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Biosynthetic Origin of Unusual 4-MethyloxazolineNRPS responsible for amicetin biosynthesis (Figure S6).
Although these strains are not known to produce peptides con-
taining a-methyl-L-serine, this bioinformatic analysis suggests
that these strains may be potential producers of such peptides,
and that NRPs containing a-methyl-L-serine may be produced
by a broader range of organisms than expected. The FmoH-
based genome mining may result in the discovery of novel com-
pounds containing an a-methyl-L-serine moiety.
SIGNIFICANCE
In this study, we identified the biosynthetic origin of the
unusual 4-methyloxazoline moiety of JBIR-34 and -35 as
a-methyl-L-serine. We showed that the A domain of FmoA3
recognizes a-methyl-L-serine. Because the ability of NRPSs
to utilize nonproteinogenic amino acids is important for the
structural diversity of NRPs, this study will open the way for
synthesizing novel NRPs by genetic engineering of NRPSs.
We also revealed that FmoH, a glycine/serine hydroxyme-
thyltransferase homolog, catalyzed the conversion between
D-alanine and a-methyl-L-serine, indicating that FmoH func-
tions as an a-methyl-L-serine synthase. Our in vitro analysis
of FmoH is a characterization of a-methyl-L-serine synthase
that correlates with NRP biosynthesis. Identification of the
a-methyl-L-serine-recognizing A domain and a-methyl-L-
serine synthase will facilitate genomemining of novel NRPs.
EXPERIMENTAL PROCEDURES
Isolation and Characterization of Compounds 3 and 4
Streptomyces sp. Sp080513GE-23 was inoculated into 100 ml of ISP-2 me-
dium (see Supplemental Experimental Procedures) and incubated at 30C
for 2 days. A portion (20 ml) of the culture was transferred into 1 l of ISP-2
medium and further incubated at 30C for 5 days. Then, 20 g of HP20 was
added to the culture and stirred at room temperature for 2 hr. The mixture
of cells and HP20 was harvested by centrifugation, and then extracted with
methanol. The extract was evaporated to dryness. The residual materials
were applied to medium pressure liquid chromatography (Purif-Compact A,
Shoko Scientific) equipped with an ODS column (Purif-Pack ODS, SIZE60,
Shoko Scientific). Compounds were eluted using linear gradient from solvent
A (10%methanol containing 0.1% formic acid) to solvent B (methanol contain-
ing 0.1% formic acid). The fractions containing compounds 3 and 4 were
evaporated to dryness, and compounds 3 and 4 in the residual material
were further purified by high performance liquid chromatography equipped
with COSMOSIL C18-AR-II (10 mm 3 250 mm). The compounds were eluted
with a linear gradient of 50%–100% methanol containing 0.1% formic acid,
resulting in 1.1 mg of compound 3 and 0.6 mg of compound 4. The 1H
NMR, 13C NMR, COSY, HMQC, and HMBC spectra of compound 3 were re-
corded in dimethyl sulfoxide (DMSO)-d6 on a JNM-A500 NMR System (JEOL,
Tokyo, Japan). The 1H NMR, 13C NMR, COSY, HMQC, and HMBC spectra of
compound 4 were recorded in DMSO-d6 on a Varian 600 NB CL NMR System
(Varian).
Construction of the Streptomyces sp. Sp080513GE-23
DfmoA3 Mutant
A PCR targeting system using the cosmid pTJ34-3 carrying the gene cluster
was used to construct the deletion mutant. The pKGLP2 vector carrying a
beta-glucuronidase as a selection marker (Myronovskyi et al., 2011) was
used. The details are described in Supplemental Experimental Procedures.
Production, Extraction, and LC-ESI MS Analysis of JBIR-34 and -35
Streptomyces sp. Sp080513GE-23 or the DfmoA3mutant was inoculated into
10ml ISP-2medium and incubated at 30C for 2 days. Two and a half milliliters
of the culture were transferred to fresh 100 ml ISP-2 medium and further incu-932 Chemistry & Biology 21, 923–934, August 14, 2014 ª2014 Elsevibated at 30C for 5 days. The supernatant was extracted with ethyl acetate
three times and further extracted with butanol twice. The butanol layer was
evaporated to dryness and the residual material was dissolved in 200 ml of
DMSO for liquid chromatography-electron spray ionization mass spectrom-
etry (LC-ESI MS) analysis. LC-ESI MS was carried out using Agilent 1100
series (Agilent Technologies) and the high-capacity trap plus system (Bruker
Daltonics) equipped with a MonoBis column (2 3 50 mm; Kyoto Monotech).
The compounds were eluted with a linear gradient using water and acetonitrile
containing 0.1% formic acid as themobile phase. The amounts of JBIR-34 and
-35 and compound 3 were estimated by integrating the corresponding peak
areas in the chromatogram (absorbance unit at 300 nm) and comparing these
values to those of the purified samples.
Feeding Experiments Using [Methyl-13C]-L-Methionine and
[3-13C]-L-Alanine
[Methyl-13C]-L-methionine and [3-13C]-L-alanine were purchased from ISOTEC
and Cambridge Isotope Laboratories, respectively. Streptomyces sp.
Sp080513GE-23 was inoculated into 10 ml ISP-2 medium and incubated at
30C for 2 days. Fifty microliters of the culture were transferred to fresh 5 ml
ISP-2 medium containing 2 g/l of [methyl-13C]-L-methionine or [3-13C]-L-
alanine and further incubated at 30C for 5 days. The supernatant was ex-
tracted with ethyl acetate three times and further extracted with butanol twice.
The butanol layer was evaporated to dryness and the residual material was
dissolved in 200 ml of DMSO for LC-ESI MS analysis. LC-ESI MS was carried
out as described previously. HR-MS/MS analysis was carried out usingWaters
SYNAPT G2 (Waters).
Expression and Purification of FmoH
pET28a-fmoH was constructed by cloning the fmoH gene amplified by PCR
into the NdeI and HindIII sites of pET28a. From the E. coli BL21(DE3) harboring
pET28a-fmoH, FmoH fused N-terminally with a histidine tag was purified as
described in Supplemental Experimental Procedures.
In Vitro Assay of FmoH
The standard reaction mixture (100 ml) contained 2 mM of FmoH, 1 mM sub-
strate, 0.5 mM THF, 10 mM PLP, and 50 mM potassium phosphate (pH 7.5).
After incubation at 30C for 1 hr, the reaction was quenched by adding
100 ml of methanol (for FDLA derivatization) or acetonitrile (for 9-fluorenylme-
thyloxycarbonyl derivatization). After derivatization was performed as
described in the Supplemental Experimental Procedures, the products were
analyzed with LC-ESI MS equippedwith aMonoBis column (23 50mm; Kyoto
Monotech). Compounds were eluted with a linear gradient using water and
acetonitrile containing 0.1% formic acid as the mobile phase. For the analysis
of the kinetic parameters, the reactionmixture (50 ml) containing 4 mMof FmoH,
different concentrations of a-methyl-L-serine (varied in the range of
50–2,000 mM), 0.5 mM THF, 20 mM PLP, and 50 mM potassium phosphate
(pH 7.5) was incubated at 30C for 5 min. The reaction was quenched by the
addition of 100 ml of acetonitrile. The 9-fluorenylmethyloxycarbonyl derivatives
were then analyzed with LC-ESI MS, and the yields were estimated by
comparing the peak areas with those of the authentic standards. The kinetic
parameters were calculated by fitting the substrate concentration-initial veloc-
ity plot to the equitation Vmax*[S]/(Km+[S]).
Expression and Purification of FmoA Proteins
The DNA fragments encoding whole fmoA1, fmoA2, fmoA3, fmoA4, and
fmoA5 were amplified by PCR and cloned into pColdI (Takara), resulting in
pColdI-fmoA1, 2, 3, 4, and 5. From the E. coli BL21(DE3) harboring one of
these plasmids, each FmoA fused N-terminally with a histidine tag was purified
as described in the Supplemental Experimental Procedures.
In Vitro Analysis of Adenylating Activity
Each FmoA protein (1 mM) was incubated with 5 mM possible substrates in
80 ml of buffer containing 150 mM hydroxylamine, 1 mM dithiothreitol, 0.4 U/
ml pyrophosphatase (Sigma), 0.5 mM ATP, 10 mM MgCl2, and 50 mM Tris-
HCl buffer (pH 7.5). Hydroxylamine solution was prepared according to the
method reported by Kadi and Challis (2009). The reaction mixture was prein-
cubated for 2 min, and the reaction was initiated by adding ATP. After
30-min incubation, the reaction was quenched by adding 20 ml of workinger Ltd All rights reserved
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Biosynthetic Origin of Unusual 4-Methyloxazolinereagent of malachite green phosphate assay kit (BioAssay Systems). After a
1.5-hr incubation at room temperature, absorption at 620 nm (A620) was
measured. We subtracted the A620 value of the reaction mixture with no sub-
strate from the A620 value of a reaction mixture containing the substrate to
estimate the relative adenylation activity.
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